Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 65601-65650 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06099756
Discharge Readmission Analysis and Management in Sepsis (DReAMS-2)
N/ARecruiting
2,000 participants
Started: Oct 26, 2023 · Completed: Oct 31, 2024
1 condition2 sponsors3 locations
NCT05873686
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
PHASE1Recruiting
140 participants
Started: Oct 26, 2023 · Completed: Jul 31, 2027
6 conditions1 sponsor7 locations
NCT06054035
SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes
PHASE4Recruiting
170 participants
Started: Oct 26, 2023 · Completed: Sep 30, 2027
3 conditions4 sponsors9 locations
NCT05923489
Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients
NARecruiting
2,618 participants
Started: Oct 26, 2023 · Completed: Oct 15, 2029
1 condition9 sponsors1 location
NCT06247605
A Phase IIII Study of AL8326 in Small Cell Lung Cancer
PHASE3Recruiting
243 participants
Started: Oct 26, 2023 · Completed: Jul 31, 2029
1 condition1 sponsor1 location
NCT05655091
Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection
PHASE2Recruiting
36 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06004856
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
PHASE3Recruiting
195 participants
Started: Oct 26, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor45 locations
NCT05725655
Hot Water Immersion After Myocardial Infarction
NARecruiting
30 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05792007
Study of the Medullary Microenvironment in Acute Childhood Leukemia
NARecruiting
40 participants
Started: Oct 26, 2023 · Completed: Oct 24, 2028
2 conditions1 sponsor3 locations
NCT05848895
OPT-IN: Osteopathic Plagiocephaly Treatment for Infants and Neonates
NARecruiting
122 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT06911697
Study on c-Met Targeted PET/CT Imaging in NSCLC
NARecruiting
88 participants
Started: Oct 26, 2023 · Completed: Jun 28, 2025
2 conditions2 sponsors1 location
NCT05984888
Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer
NARecruiting
43 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05929859
Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders
PHASE1/PHASE2Recruiting
84 participants
Started: Oct 26, 2023 · Completed: Feb 29, 2028
1 condition4 sponsors1 location
NCT06066905
A Study of Chidamide With AZA in MRD Positive AML After Transplant
NARecruiting
60 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06103201
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
PHASE1Recruiting
15 participants
Started: Oct 26, 2023 · Completed: Nov 26, 2027
2 conditions1 sponsor1 location
NCT06049212
Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)
PHASE1Recruiting
30 participants
Started: Oct 26, 2023 · Completed: Jan 29, 2027
5 conditions1 sponsor7 locations
NCT06106360
A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy
N/ARecruiting
100 participants
Started: Oct 26, 2023 · Completed: Dec 26, 2025
2 conditions1 sponsor1 location
NCT06182696
OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM
PHASE1/PHASE2Recruiting
83 participants
Started: Oct 26, 2023 · Completed: Aug 31, 2028
1 condition1 sponsor5 locations
NCT06143007
A Phase 1 Study of BB3008 in Participants With Advanced Solid Tumors
PHASE1Recruiting
42 participants
Started: Oct 26, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor2 locations
NCT05935371
Consequences of Obstetric Anal Sphincter Injuries on Maternal Psychology and Relationship Experience
N/ARecruiting
87 participants
Started: Oct 26, 2023 · Completed: Oct 31, 2025
7 conditions2 sponsors1 location
NCT05939999
Effects of Elastic Tape on Pulmonary Rehabilitation of Patients with Chronic Obstructive Pulmonary Disease
NARecruiting
42 participants
Started: Oct 26, 2023 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT06725758
Two-part, First-in-Human Study on ODM-212 in Subjects with Selected Advanced Solid Tumours
PHASE1/PHASE2Recruiting
315 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT07007741
Digital Therapy for Fatty Liver Disease
NARecruiting
120 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05799040
Evaluation of the Effectiveness of the Self-developed Pulmonary Lobar Ventilation Detector
N/ARecruiting
40 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06190184
Viome Precision Nutritional Programs to Improve Clinical Outcomes for Mental Health Conditions
NARecruiting
60 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2024
9 conditions1 sponsor1 location
NCT05985109
KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer
PHASE2Recruiting
98 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05987423
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease
PHASE3Active, not recruiting
131 participants
Started: Oct 26, 2023 · Completed: Jul 1, 2026
2 conditions1 sponsor46 locations
NCT06094582
Knowledges and Use of Cannabidiol in Older Adults
N/ARecruiting
140 participants
Started: Oct 26, 2023 · Completed: May 31, 2024
2 conditions1 sponsor1 location
NCT05899608
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
PHASE3Recruiting
1,080 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor219 locations
NCT06109246
The Patient Enablement Instrument for Back Pain Turkish Version, Validity and Reliability Study
N/ANot yet recruiting
60 participants
Started: Oct 26, 2023 · Completed: Dec 30, 2023
1 condition1 sponsor1 location
NCT06100328
Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE)
N/ARecruiting
40 participants
Started: Oct 26, 2023 · Completed: Jul 31, 2030
1 condition1 sponsor1 location
NCT06009523
Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation
NARecruiting
50 participants
Started: Oct 26, 2023 · Completed: Dec 1, 2027
1 condition1 sponsor2 locations
NCT05952271
Herpes Zoster Hospitalizations in Italy
N/ARecruiting
72,000 participants
Started: Oct 26, 2023 · Completed: Jul 30, 2025
2 conditions2 sponsors1 location
NCT06104046
Prevalence of Seroconversion of Hepatitis c Virus Among Children With CKD on Regular Hemodialysis
N/ANot yet recruiting
50 participants
Started: Oct 26, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor0 locations
NCT05710666
Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)
PHASE2Active, not recruiting
11 participants
Started: Oct 26, 2023 · Completed: Mar 30, 2028
1 condition1 sponsor5 locations
NCT05440864
Durvalumab and Tremelimumab in Resectable HCC
PHASE2Recruiting
28 participants
Started: Oct 26, 2023 · Completed: Nov 30, 2026
1 condition3 sponsors3 locations
NCT06225856
An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies
PHASE1Recruiting
96 participants
Started: Oct 26, 2023 · Completed: Dec 30, 2026
2 conditions1 sponsor1 location
NCT06057376
Impact of Two Dietary Interventions on Simple Carbohydrate Intolerance
NARecruiting
40 participants
Started: Oct 26, 2023 · Completed: Feb 28, 2026
1 condition3 sponsors1 location
NCT06227962
Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors
N/AEnrolling by invitation
660 participants
Started: Oct 26, 2023 · Completed: Mar 31, 2028
3 conditions1 sponsor1 location
NCT06401850
Polycystic Ovary Syndrome and Education
NARecruiting
70 participants
Started: Oct 26, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT06001242
The Relationship Between Upper Extremity Explosive Power and Trunk Muscles in Volleyball Players
N/ANot yet recruiting
30 participants
Started: Oct 26, 2023 · Completed: Aug 26, 2025
3 conditions1 sponsor1 location
NCT06019923
Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer
N/ARecruiting
100 participants
Started: Oct 26, 2023 · Completed: Sep 10, 2027
1 condition1 sponsor1 location
NCT06026319
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
PHASE1Recruiting
24 participants
Started: Oct 26, 2023 · Completed: Jan 1, 2028
10 conditions1 sponsor1 location
NCT05674994
Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
PHASE3Recruiting
110 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor29 locations
NCT06895291
Whole Body MRI in Oncology
N/ARecruiting
1,000 participants
Started: Oct 26, 2023 · Completed: Oct 31, 2031
6 conditions1 sponsor3 locations
NCT05834244
A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)
PHASE1Recruiting
32 participants
Started: Oct 26, 2023 · Completed: Jun 30, 2028
1 condition1 sponsor2 locations
NCT06495281
Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus Patients
N/ARecruiting
3,000 participants
Started: Oct 26, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05632406
Breathing & Blood Pressure
N/ARecruiting
80 participants
Started: Oct 25, 2023 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT06112041
The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0)
PHASE2Not yet recruiting
29 participants
Started: Oct 25, 2023 · Completed: Oct 30, 2026
2 conditions1 sponsor1 location
NCT06028659
Investigation of in Vivo Endogenous and/or Exogenous Production of Phenolic Metabolites Using (un)Targeted Metabolomics
NARecruiting
30 participants
Started: Oct 25, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location